Name: Liquid Biopsy in Cancer Diagnostics Market in United States, United Kingdom– Market Outlook, Unmet Needs, Market Assessment &amp; Forecast (2023-2030)
SKU: 17089
Availability: InStock

Liquid Biopsy in Cancer Diagnostics Market – Report Overview

Pacific Business Consulting’s “Liquid Biopsy in Cancer Diagnostics Market in 10MM – Market Outlook, Unmet Needs, Market Assessment & Forecast (2023-2030)” report offers a comprehensive understanding of Liquid Biopsy in Cancer Diagnostics market, encompassing historical and projected market size data, along with market trends, market drivers, market barriers and unmet medical needs in the Ten Major Markets (10MM) of the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, China, Australia, and India.

The global Liquid Biopsy in Cancer Diagnostics market, valued at US$ 8.0 Billion in 2022, is projected to grow at a Compound Annual Growth Rate (CAGR) of more than 15.0% from 2023 to 2030, reaching a value of more than US$ 20.0 Billion by 2030.

Liquid biopsy has emerged as a convenient, fast, non-invasive, and reproducible sampling method for cancer diagnostics. It reflects changes in the tumor gene expression profile and provides a robust foundation for individualized therapy and early cancer diagnosis. Liquid biopsy has gained widespread attention as a non-invasive alternative to tissue biopsy, focusing on screening early cancer, monitoring tumor progression, assessing therapeutic response and clinical prognosis, and detecting recurrent and refractory tumors.

The World Health Organization (WHO) reported around 10 million cancer-related deaths in 2020, emphasizing the demand for convenient and precise cancer diagnostic tests for early detection. Governments of different economies are providing funds for improved cancer outcomes, with the National Cancer Institute in the United States, for example, receiving US$ 119 million in 2021.

Researchers continue to advance biomarkers for cancer detection and evaluation using liquid biopsy. The development of new biomarkers for early cancer detection and treatment response is a key aspect contributing to the growth of liquid biopsy in cancer diagnostics.

The increasing prominence of precision medicine in cancer care is another significant driver of the demand for liquid biopsy. Precision medicine involves individualizing treatment plans based on the biological behavior of the tumor. Liquid biopsy plays a crucial role in providing real-time information about the tumor profile, aiding in customized treatment decisions. Market players are recognizing the potential of liquid biopsy, as evident from their interest in product development in this domain.

Advancements such as next-generation sequencing for advanced cancer patients in liquid biopsies, the rise in the number of cancer patients, and patient preference for minimally invasive therapies contribute to the growth of the liquid biopsy market. However, lack of awareness in developing regions is a limiting factor. The increase in healthcare expenditure in developing countries and the use of liquid biopsy tests to treat rare cancers present opportunities for market growth.

Key players in the Liquid Biopsy in Cancer Diagnostics segment, including Illumina Inc, QIAGEN, Lucence Health Inc, Personal Genome Diagnostics Inc, SAGA Diagnostics, Agena Bioscience Inc., Thermo Fisher Scientific Inc, Biocept Inc, Agilent Technologies Inc, MDx Health, NeoGenomics Laboratories, F. Hoffmann-La Roche Ltd, Myriad Genetics Inc, Exact Sciences Corporation, Biocartis, and Sysmex Corporation, are expected to shape the future landscape of Liquid Biopsy in Cancer Diagnostics technologies through ongoing innovation.

Scope of Report

The report addresses critical subjects such as strategic competitor evaluation, market characterization, unmet needs, and the consequences of these elements for the Liquid Biopsy in Cancer Diagnostics market. It also delves into the analysis of present and prospective market competition within the global Liquid Biopsy in Cancer Diagnostics market.

Furthermore, the report offers an insightful examination of the primary industry drivers, constraints, and challenges. Each trend undergoes independent research to furnish qualitative analysis regarding its implications.

Reasons to Buy

Develop your business strategies by gaining insights into the trends that shape and drive the Liquid Biopsy in Cancer Diagnostics market across the 10MM (Ten Major Markets).
Increase revenue by comprehending key trends, innovative products and technologies, market segments, and companies poised to influence the future of the 10MM Liquid Biopsy in Cancer Diagnostics market.
Craft effective sales and marketing strategies by thoroughly understanding the competitive landscape and analyzing the performance of various competitors.
Identify emerging players with potentially robust product portfolios and devise strategic counter-strategies to gain a competitive advantage.
Optimize your sales and marketing efforts by pinpointing market categories and segments that offer the greatest opportunities for consolidations, investments, and strategic partnerships.

Executive Summary: Liquid Biopsy in Cancer Diagnostics
- Global Market Outlook: Liquid Biopsy in Cancer Diagnostics
Competitive Intelligence Analysis: Liquid Biopsy in Cancer Diagnostics
Therapeutic Sector SWOT
Technology Roadmap Analysis: Liquid Biopsy in Cancer Diagnostics
Market Background
- Drivers
- Restraints
- Opportunity
- Key Market Trends
- Key Unmet Needs
Key Marketed Products Profile – Major Approved Products: Liquid Biopsy in Cancer Diagnostics
- Product Profile
- Safety and Efficacy
Regulatory Landscape
Liquid Biopsy in Cancer Diagnostics: Ten Major Market (10MM) – Market Analysis, By Cancer Type
- Breast Cancer
- Colorectal Cancer
- Prostate Cancer
- Lung Cancer
- Others
Liquid Biopsy in Cancer Diagnostics: Ten Major Market (10MM) – Market Analysis, By Biomarker Type
- Circulating Tumor Cells (CTCs)
- Circulating Tumor DNA (ctDNA)
- Circulating Free DNA (cfDNA)
- Others
Liquid Biopsy in Cancer Diagnostics: Ten Major Market (10MM) – Market Analysis, By End User
- Hospitals
- Diagnostic Centers
- Academic & Research Organizations
- Others
Liquid Biopsy in Cancer Diagnostics: Ten Major Market (10MM) – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Cancer Type
  - By Biomarker Type
  - By End User
- Current and Future Market Projections (US$ million), 2023-2030
  - By Cancer Type
  - By Biomarker Type
  - By End User

S. Liquid Biopsy in Cancer Diagnostics – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Cancer Type
  - By Biomarker Type
  - By End User
- Current and Future Market Projections (US$ million), 2023-2030
  - By Cancer Type
  - By Biomarker Type
  - By End User

K. Liquid Biopsy in Cancer Diagnostics – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Cancer Type
  - By Biomarker Type
  - By End User
- Current and Future Market Projections (US$ million), 2023-2030
  - By Cancer Type
  - By Biomarker Type
  - By End User

Germany Liquid Biopsy in Cancer Diagnostics – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Cancer Type
  - By Biomarker Type
  - By End User
- Current and Future Market Projections (US$ million), 2023-2030
  - By Cancer Type
  - By Biomarker Type
  - By End User

France Liquid Biopsy in Cancer Diagnostics – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Cancer Type
  - By Biomarker Type
  - By End User
- Current and Future Market Projections (US$ million), 2023-2030
  - By Cancer Type
  - By Biomarker Type
  - By End User

Italy Liquid Biopsy in Cancer Diagnostics – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Cancer Type
  - By Biomarker Type
  - By End User
- Current and Future Market Projections (US$ million), 2023-2030
  - By Cancer Type
  - By Biomarker Type
  - By End User

Spain Liquid Biopsy in Cancer Diagnostics – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Cancer Type
  - By Biomarker Type
  - By End User
- Current and Future Market Projections (US$ million), 2023-2030
  - By Cancer Type
  - By Biomarker Type
  - By End User

Japan Liquid Biopsy in Cancer Diagnostics – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Cancer Type
  - By Biomarker Type
  - By End User
- Current and Future Market Projections (US$ million), 2023-2030
  - By Cancer Type
  - By Biomarker Type
  - By End User

China Liquid Biopsy in Cancer Diagnostics – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Cancer Type
  - By Biomarker Type
  - By End User
- Current and Future Market Projections (US$ million), 2023-2030
  - By Cancer Type
  - By Biomarker Type
  - By End User

Australia Liquid Biopsy in Cancer Diagnostics – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Cancer Type
  - By Biomarker Type
  - By End User
- Current and Future Market Projections (US$ million), 2023-2030
  - By Cancer Type
  - By Biomarker Type
  - By End User

India Liquid Biopsy in Cancer Diagnostics – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Cancer Type
  - By Biomarker Type
  - By End User
- Current and Future Market Projections (US$ million), 2023-2030
  - By Cancer Type
  - By Biomarker Type
  - By End User

Competitive Landscape
- Company Overview
- Product Portfolio
- Key Financials
- Sales Footprint

Note – All Major Company Profiles (Count up to 20) will be covered in the report

Assumptions and Acronyms Used
Research Methodology
- Secondary Research
- Primary Research
- Data Triangulation
Geographic Scope
- The U.S., The U.K., Germany, France, Italy, Spain, Japan, China, Australia, and India
Copyrights and Disclaimer

Liquid Biopsy in Cancer Diagnostics Market in United States, United Kingdom– Market Outlook, Unmet Needs, Market Assessment & Forecast (2023-2030)

License Type (Price in USD)

Customize Reports As Per Your Needs

Have A Question?

Phone:+919599779105
Email:info@pacificbusinessconsulting.com

RELATED PRODUCTS

Acute Myeloid Leukemia (AML) Market in United States, United Kingdom – Market Outlook, Market Assessment and Market Forecast (2023-2030)

Chronic Lymphocytic Leukemia (CLL) Market in United States, United Kingdom– Market Outlook, Unmet Needs, Market Assessment and Forecast (2023-2030)

Female Contraceptives Market in United States, United Kingdom– Market Insights, Unmet Needs and Market Forecast (2023-2030)

Insomnia Market in United States, United Kingdom– Market Insights, Unmet Needs, Market Assessment and Forecast (2023-2030)

Parkinson’s Disease (PD) Market in United States, United Kingdom– Market Insights, Unmet Needs, Market Assessment and Forecast (2023-2030)

Useful Links

Consulting

Get In Touch